Evidence map›Paper›PMID 41935632›Full record

ArticleJournal of lipid research2026

In vivo visualization of lipophagy dynamics using the tfLiveDrop reporter mice.

Siqiao Gong, Qiaofei Zhang, Hongluan Wu, Xiaocui Chen, Lijing Liu, Yongming Chen, ZeSen Feng, Shangmei Li, Hongyong Su, Jiansong Qi and 4 more

Abstract read
In one paragraph

Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Siqiao GongNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Qiaofei ZhangNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Hongluan WuNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xiaocui ChenNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Lijing LiuNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Yongming ChenNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
ZeSen FengNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Shangmei LiNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Hongyong SuNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Jiansong QiNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Jixin TangNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zhennan YeNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Chen YangNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Electronic address: yangchen307@126.com.
Huafeng LiuNational Clinical Key Specialty Construction Program (2023), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Department of Nephrology, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Electronic address: liuhf@gdmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipophagy, a selective form of autophagy, is critical for maintaining cellular lipid homeostasis. However, understanding its dynamic regulation and pathophysiological significance in vivo has been hindered by a lack of sensitive and versatile monitoring tools. To address this gap, we generated the tfLiveDrop (mCherry-eGFP-LiveDrop) reporter mouse by integrating a tandem mCherry-eGFP fluorescent probe with the lipid droplet-targeting domain of glycerol-3-phosphate acyltransferase 4 (GPAT4, the rate-limiting enzyme in triacylglycerol synthesis), termed the LiveDrop domain. This model enables real-time, spatiotemporal visualization of lipophagic flux at single-cell resolution in living animals. We initially validated the sensitivity and specificity of the tfLiveDrop reporter in primary renal tubular epithelial cells (TECs). Systemic mapping of lipophagic activity across organs revealed pronounced heterogeneity in basal lipophagic activity under physiological conditions. Furthermore, in a model of type 2 diabetes, we demonstrated that lipophagic flux is dysregulated in a tissue-specific manner in male mice, underscoring its pivotal role in disease-associated lipid metabolism. Notably, longitudinal tracking during kidney development uncovered a programmed wave of lipophagic activity that is essential for lipid homeostasis during renal maturation. Our findings provide a powerful and versatile platform for in vivo lipophagy research, establishing a foundation for elucidating its functional contributions to metabolic disorders and organ development.

Indexed as

AutophagyGenes, ReporterGlycerol-3-Phosphate O-AcyltransferaseLipid MetabolismAnimalsDiabetes Mellitus, Type 2Green Fluorescent ProteinsMaleMiceGlycerol-3-Phosphate O-AcyltransferaseGreen Fluorescent Proteinskidney developmentlipid dropletslipophagyLiveDroptype 2 diabetes

Identifiers

PMID41935632
PMCPMC13137028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.